Crispr Therapeutics shares owned by Tudor Investment Corporation
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Tudor Investment Corporation
from 13F filings
Historical chart of Tudor Investment Corporation investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Tudor Investment Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.9M | 42k | 68.16 |
| 2023-12-31 | $3.4M | 54k | 62.60 |
| 2023-06-30 | $1.4M | 26k | 56.14 |
| 2022-12-31 | $1.0M | 25k | 40.64 |
| 2022-09-30 | $1.6M | 24k | 65.33 |
| 2022-06-30 | $1.2M | 20k | 60.77 |
| 2022-03-31 | $1.6M | 25k | 62.76 |
| 2021-12-31 | $1.9M | 25k | 75.80 |
| 2021-09-30 | $2.4M | 21k | 111.95 |
| 2020-12-31 | $2.4M | 16k | 153.08 |
| 2020-09-30 | $584k | 7.0k | 83.63 |
| 2020-06-30 | $372k | 5.1k | 73.42 |
| 2020-03-31 | $477k | 11k | 42.40 |
| 2019-12-31 | $1.0M | 17k | 60.90 |
| 2018-03-31 | $393k | 8.6k | 45.66 |
More positions owned by Tudor Investment Corporation
View all positions for Tudor Investment Corporation